Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederick G Hayden

Showing results (81-90 of 157) with videos related to

Pageof 16
Sort By:
Antiviral Therapy|February 8, 2012
Current research on respiratory viral infections: XIIth International SymposiumMatthijs R A Welkers, Jake Dunning, Chi-Huey Wong, et al.
Journal of the Pediatric Infectious Diseases Society|December 19, 2020
Baloxavir Treatment in Adolescents With Acute Influenza: Subgroup Analysis From the CAPSTONE-1 TrialSimon Portsmouth, Frederick G Hayden, Keiko Kawaguchi, et al.
Antiviral Therapy|May 15, 2002
Oral pleconaril treatment of picornavirus-associated viral respiratory illness in adults: efficacy and tolerability in phase II clinical trialsFrederick G Hayden, Teresa Coats, Kenneth Kim, et al.
The Journal of General Virology|October 22, 2002
A release-competent influenza A virus mutant lacking the coding capacity for the neuraminidase active siteLarisa V Gubareva, Marina S Nedyalkova, Dmitri V Novikov, et al.
Antiviral Therapy|March 27, 2009
Effects of dietary supplementation with conjugated linoleic acid on experimental human rhinovirus infection and illnessKristine M Peterson, Marianne O'Shea, Wiro Stam, et al.
Antiviral Therapy|October 9, 2009
Surveillance for neuraminidase-inhibitor-resistant influenza viruses in Japan, 1996-2007Masato Tashiro, Jennifer L McKimm-Breschkin, Takehiko Saito, et al.
The Lancet. Infectious Diseases|June 12, 2020
Early treatment with baloxavir marboxil in high-risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE-2): a randomised, placebo-controlled, phase 3 trialMichael G Ison, Simon Portsmouth, Yuki Yoshida, et al.
Antimicrobial Agents and Chemotherapy|October 28, 2005
Relationship of pleconaril susceptibility and clinical outcomes in treatment of common colds caused by rhinovirusesDaniel C Pevear, Frederick G Hayden, Tina M Demenczuk, et al.
Archives of Otolaryngology--Head & Neck Surgery|February 15, 2002
Expression of ICAM-1 in nasal epithelium and levels of soluble ICAM-1 in nasal lavage fluid during human experimental rhinovirus infectionBirgit Winther, Eurico Arruda, Theodore J Witek, et al.
Journal of Infection and Public Health|April 7, 2016
The search for therapeutic options for Middle East Respiratory Syndrome (MERS)Yaseen M Arabi, Hanan H Balkhy, Frederick G Hayden, et al.
Pageof 16

Showing results (81-90 of 157) with videos related to

Sort By:
Pageof 16
Antiviral Therapy|February 8, 2012
Current research on respiratory viral infections: XIIth International SymposiumMatthijs R A Welkers, Jake Dunning, Chi-Huey Wong, et al.
Journal of the Pediatric Infectious Diseases Society|December 19, 2020
Baloxavir Treatment in Adolescents With Acute Influenza: Subgroup Analysis From the CAPSTONE-1 TrialSimon Portsmouth, Frederick G Hayden, Keiko Kawaguchi, et al.
Antiviral Therapy|May 15, 2002
Oral pleconaril treatment of picornavirus-associated viral respiratory illness in adults: efficacy and tolerability in phase II clinical trialsFrederick G Hayden, Teresa Coats, Kenneth Kim, et al.
The Journal of General Virology|October 22, 2002
A release-competent influenza A virus mutant lacking the coding capacity for the neuraminidase active siteLarisa V Gubareva, Marina S Nedyalkova, Dmitri V Novikov, et al.
Antiviral Therapy|March 27, 2009
Effects of dietary supplementation with conjugated linoleic acid on experimental human rhinovirus infection and illnessKristine M Peterson, Marianne O'Shea, Wiro Stam, et al.
Antiviral Therapy|October 9, 2009
Surveillance for neuraminidase-inhibitor-resistant influenza viruses in Japan, 1996-2007Masato Tashiro, Jennifer L McKimm-Breschkin, Takehiko Saito, et al.
The Lancet. Infectious Diseases|June 12, 2020
Early treatment with baloxavir marboxil in high-risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE-2): a randomised, placebo-controlled, phase 3 trialMichael G Ison, Simon Portsmouth, Yuki Yoshida, et al.
Antimicrobial Agents and Chemotherapy|October 28, 2005
Relationship of pleconaril susceptibility and clinical outcomes in treatment of common colds caused by rhinovirusesDaniel C Pevear, Frederick G Hayden, Tina M Demenczuk, et al.
Archives of Otolaryngology--Head & Neck Surgery|February 15, 2002
Expression of ICAM-1 in nasal epithelium and levels of soluble ICAM-1 in nasal lavage fluid during human experimental rhinovirus infectionBirgit Winther, Eurico Arruda, Theodore J Witek, et al.
Journal of Infection and Public Health|April 7, 2016
The search for therapeutic options for Middle East Respiratory Syndrome (MERS)Yaseen M Arabi, Hanan H Balkhy, Frederick G Hayden, et al.
Pageof 16